Finally, we observe that both NRXN1 and NLGN1 are expressed in the N-CAM positive neuronal cells within the prostate tumour stroma, with overall slightly higher expression profiles in high-risk patients (Fig. 5d, e). Here, NRXN1 is linked to prostate neoplasm.